Complete report $2,250. DataPack (test volumes, sales forecasts, supplier shares) $1,450.
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the five ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.
This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by market segment.
The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 115 pages and 6 tables
SIMILAR MARKET STUDIES
This DataPack contains tables from VPGMarketResearch.com new report, 2016 World Rabies Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Suppliers. For pricing information on DataPack sections or individual tables, please contact Customer Service.
February 2016 | $0 | View Details >>
Complete report $7,900. DataPack (test volumes, sales forecasts, supplier shares) $5,100.This new 318-page report from VPGMarketResearch.com provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD ...
January 2017 | $0 | View Details >>
World Blood Typing, Grouping and Infectious Disease Screening Market 2014” is a new seven-country strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.
January 2014 | $19500 | View Details >>
Complete report $6,800. DataPack (test volumes, sales forecasts, supplier shares) $3,450.“2015-2019 Germany Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the German cancer diagnostics markets; reviews current and emerging tests; analyzes ...
September 2015 | $4350 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research